PDS Biotechnology Corporation
PDSB
$1.32
$0.12510.50%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/25/2025
-
TipRanks Financial Blog
8/25/2025
-
The Fly
8/25/2025
-
Globe Newswire
8/17/2025
-
MarketBeat
8/16/2025
-
MarketBeat
8/14/2025
-
GuruFocus
8/14/2025
-
PR Newswire
8/14/2025
-
CNW Group - News Releases
8/14/2025
-
Insider Monkey
8/13/2025
-
Seeking Alpha: Transcripts
8/13/2025
-
SeekingAlpha
PDS Biotechnology Corp Q2 2025 Earnings: EPS of -$0.21 Beats Estimate, Reports $9.4 Million Net Loss
8/13/2025
-
GuruFocus
8/13/2025
-
Fool.com Headlines
8/13/2025
-
SeekingAlpha.com: All News
8/13/2025
-
The Fly
8/13/2025
-
Globe Newswire
8/12/2025
-
Benzinga
8/6/2025
-
MarketBeat
8/6/2025
-
Globe Newswire
7/24/2025
-
MarketBeat
7/10/2025
-
GuruFocus
7/10/2025
-
TipRanks Financial Blog
7/10/2025
-
Globe Newswire
7/1/2025
-
MarketBeat
7/1/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, August 13, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
800 208 3343
Address
303A College Road East
Princeton, NJ 08540
Princeton, NJ 08540
Country
Year Founded
Business Description
Sector
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies. The company’s lead product candidate is Versamune HPV, which...
more